SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
126 hedge funds and large institutions have $127M invested in SANGAMO THERAPEUTICS INC in 2016 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 18 closing their positions.
203% more call options, than puts
Call options by funds: $3.12M | Put options by funds: $1.03M
21% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 33
17% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 18
1% more funds holding
Funds holding: 125 → 126 (+1)
3.67% less ownership
Funds ownership: 62.37% → 58.69% (-3.7%)
38% less capital invested
Capital invested by funds: $204M → $127M (-$77.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$3.05M |
| 2 |
NC
Nexthera Capital
New York
|
+$1.83M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.46M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.27M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1,000K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$4.82M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.64M |
| 3 |
State Street
Boston,
Massachusetts
|
-$4.52M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.16M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.74M |
SGMO Hedge Fund Activity: Q4 2016 in Review
126 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2016, worth a combined $127M — down 38% from $204M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new SGMO positions and 18 closed out — a net gain of 3 holders — while 40 added to existing stakes and 33 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $3.05M. The largest seller was VOYA Investment Management, cutting an estimated $4.82M.
- 126 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2016, up from 125 in Q3 2016.
- Funds reported $127M of SANGAMO THERAPEUTICS INC stock for Q4 2016, down 38% quarter-over-quarter.
- 21 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2016 and 18 closed out, a net change of +3 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2016 was Deerfield Management, an estimated $3.05M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2016 was VOYA Investment Management, an estimated $4.82M sold.
Based on aggregated 13F filings for Q4 2016.